Exagen Inc. to Participate in the 2024 Cantor Global Healthcare Conference
04 sept. 2024 16h05 HE
|
Exagen Inc.
CARLSBAD, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2024 Cantor Global...
Elevar Therapeutics to Present at Cantor Fitzgerald Global Healthcare Conference
21 sept. 2023 09h00 HE
|
Elevar Therapeutics
FORT LEE, N.J., Sept. 21, 2023 (GLOBE NEWSWIRE) -- Elevar Therapeutics, Inc., a majority-owned subsidiary of HLB Co., Ltd. and a fully integrated biopharmaceutical company dedicated to elevating...
Theratechnologies fera une présentation à la conférence Cantor Fitzgerald Global Healthcare 2023
20 sept. 2023 07h00 HE
|
Theratechnologies
MONTRÉAL, 20 sept. 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (« Theratechnologies » ou la « Société ») (TSX : TH) (NASDAQ : THTX), une société biopharmaceutique axée sur la mise au point...
Theratechnologies to Present at the Cantor Fitzgerald Global Healthcare Conference 2023
20 sept. 2023 07h00 HE
|
Theratechnologies
MONTREAL, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Theratechnologies Inc. (“Theratechnologies” or the “Company”) (TSX: TH) (NASDAQ: THTX), a biopharmaceutical company focused on the development and...
Exagen Inc. to Participate in the 2023 Cantor Fitzgerald Global Healthcare Conference
12 sept. 2023 16h05 HE
|
Exagen Inc.
SAN DIEGO, California, Sept. 12, 2023 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the 2023 Cantor...
Cerberus Sentinel Announces Proposed Public Offering of Common Stock
13 févr. 2023 16h01 HE
|
Cerberus Sentinel
Scottsdale, Ariz., Feb. 13, 2023 (GLOBE NEWSWIRE) -- via InvestorWire -- Cerberus Cyber Sentinel Corporation (“Cerberus Sentinel” or the “Company”) (NASDAQ: CISO), an industry leader as a managed...
Exagen Inc. to Participate in Fourth Quarter Investor Conferences
08 nov. 2022 16h05 HE
|
Exagen Inc.
SAN DIEGO, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced that management will participate in the following fourth...
Processa Pharmaceuticals to Participate in Upcoming Investor Conferences
16 sept. 2021 08h30 HE
|
Processa Pharmaceuticals, Inc.
HANOVER, MD, Sept. 16, 2021 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to...
Aptinyx to Present at the 2019 Cantor Fitzgerald Global Healthcare Conference
30 sept. 2019 07h03 HE
|
Aptinyx Inc.
EVANSTON, Ill., Sept. 30, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (Nasdaq: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and...
Biofrontera to Present at the Cantor Fitzgerald Global Healthcare Conference
24 sept. 2018 07h44 HE
|
Biofrontera AG
Leverkusen, Germany, Sept. 24, 2018 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F), an international biopharmaceutical company, today announced that Thomas...